D Oertli
Overview
Explore the profile of D Oertli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
875
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weber W, Soysal S, Fulco I, Barandun M, Babst D, Kalbermatten D, et al.
Eur J Surg Oncol
. 2017 Feb;
43(7):1236-1243.
PMID: 28214053
The emphasis on esthetic outcomes and quality of life after breast cancer surgery has motivated surgeons to develop oncoplastic breast conserving surgery (OPS). Training programs are still rare in most...
2.
Hess G, Schafer J, Rosenthal R, Kettelhack C, Oertli D
Colorectal Dis
. 2016 Nov;
19(6):582-588.
PMID: 27805772
Aim: Hartmann's procedure (HP) is commonly used for the emergency treatment of complicated sigmoid diverticulitis (CSD). It is intended to restore intestinal continuity; however, in practice, reversal is not carried...
3.
Guarnero V, Hoffmann H, Hetzer F, Oertli D, Turina M, Zingg U, et al.
Tech Coloproctol
. 2016 Mar;
20(5):293-297.
PMID: 27000858
Background: Parastomal hernias (PSH) are one of the most frequent complications of enterostomies with a non-negligible complication rate and a significant socioeconomic effect. Therefore, preventing PSH by placing a mesh...
4.
Amicarella F, Muraro M, Hirt C, Cremonesi E, Padovan E, Mele V, et al.
Gut
. 2016 Jan;
66(4):692-704.
PMID: 26719303
Background: The immune contexture predicts prognosis in human colorectal cancer (CRC). Whereas tumour-infiltrating CD8+ T cells and myeloid CD16+ myeloperoxidase (MPO)+ cells are associated with favourable clinical outcome, interleukin (IL)-17-producing...
5.
Soysal S, Muenst S, Kan-Mitchell J, Huarte E, Zhang X, Wilkinson-Ryan I, et al.
Breast Cancer Res Treat
. 2014 Sep;
147(3):527-37.
PMID: 25212176
Mammaglobin-A (MAM-A) is a secretory protein that is overexpressed in 80 % of human breast cancers. Its near-universal expression in breast cancer as well as its exquisite tissue specificity makes...
6.
Muenst S, Daster S, Obermann E, Droeser R, Weber W, von Holzen U, et al.
Dis Markers
. 2013 Nov;
35(5):337-44.
PMID: 24191127
Background: Snail is a key regulator of epithelial-mesenchymal transition of tumor cells. Several studies have shown nuclear Snail expression to be a negative prognostic factor in human cancer, where it...
7.
Muenst S, Soysal S, Gao F, Obermann E, Oertli D, Gillanders W
Breast Cancer Res Treat
. 2013 Jun;
139(3):667-76.
PMID: 23756627
Programmed death 1 (PD-1) is a co-inhibitory receptor in the CD28/CTL-4 family, and functions as a negative regulator of the immune system. Tumor-infiltrating lymphocytes (TIL) in many epithelial cancers express...
8.
Soysal S, Muenst S, Barbie T, Fleming T, Gao F, Spizzo G, et al.
Br J Cancer
. 2013 Mar;
108(7):1480-7.
PMID: 23519058
Background: Epithelial cell adhesion molecule (EpCAM) is frequently expressed in breast cancer, and its expression has been associated with poor prognosis. Breast cancer can be subdivided into intrinsic subtypes, differing...
9.
Soysal S, Obermann E, Gao F, Oertli D, Gillanders W, Viehl C, et al.
Breast Cancer Res Treat
. 2012 Dec;
137(2):637-44.
PMID: 23242616
Protein tyrosine phosphatase 1B (PTP1B) is a non-transmembrane protein tyrosine phosphatase that has come into focus as a critical regulator of multiple signaling pathways. The role of PTP1B in breast...
10.
Delko T, Kostler T, Peev M, Oertli D, Zingg U
Obes Surg
. 2012 Nov;
23(3):279-86.
PMID: 23135881
Roux-en-Y gastric bypass (RYGB) is the gold standard in bariatric surgery. The effect of the procedure is based on restriction, malabsorption and changes in hormonal axis. Ghrelin is an important...